Erysipelas

Erysipelas (erysipelas) is an acute infectious disease characterized by inflammation of the skin and subcutaneous tissue. It is usually caused by group A streptococci and manifests itself as bright redness, swelling and pain in the affected area. Most often, erysipelas occurs on the lower extremities and face, without affecting the deep layers of the skin. The pathology can occur as an independent disease, as well as against the background of other infectious processes, such as lymphadenitis or lymphangitis. Symptoms of erysipelas may include fever, chills, general weakness, as well as local manifestations such as inflammation and hyperemia of the skin, which increase over several hours.

History of the disease and interesting historical facts

Erysipelas has a long history dating back thousands of years. The disease was mentioned in medical texts from the ancient world, including Hippocrates and Galen, where it was described as “hot, purulent sores.” In the Middle Ages, erysipelas was considered a curse, and many patients were treated with bloodletting and other questionable methods. With the development of microbiology in the 19th century, it became known that erysipelas is caused by streptococcal infections, which allowed for significant improvements in approaches to treating and preventing the disease. However, throughout history, medicine has faced difficulties in treating the disease due to its tendency to relapse and complications.

Epidemiology

Erysipelas is a common disease, especially in tropical and subtropical regions. According to existing data, its incidence in the adult population is about 5-10 cases per 1000 people per year. In the elderly, this figure may increase to 30 cases per 1000. About 20% patients with erysipelas experience a second episode within one year of the first episode. The incidence increases in cold and wet seasons, when limited movement and trauma contribute to the penetration of infection.

Genetic predisposition to this disease

Today, there is an opinion about genetic predisposition to erysipelas, but this area of research remains poorly understood. Studies show that certain abnormalities in genes responsible for the immune response can increase the risk of developing infections caused by streptococci. For example, mutations in the IL-6 gene, which is involved in the inflammatory response, can lead to a decrease in the body's ability to cope with infection. It has also been shown that polymorphisms in genes regulating interleukin levels can contribute to the development of a chronic infectious process.

Risk factors for the development of this disease

There are various risk factors that contribute to the development of erysipelas, including:

• Having chronic diseases such as diabetes, which increases the likelihood of skin infections.
• Skin injuries: Cuts, burns and other injuries provide entry points for infection.
• Immunodeficiency conditions, including HIV and autoimmune diseases that weaken the immune response.
• The postpartum period, when women have an increased susceptibility to infections.
• Poor hygiene or failure to observe its principles also increases the risk of infection.

Diagnosis of this disease

Diagnosis of erysipelas is based on clinical manifestations and may include the following steps:

• The main symptoms are a bright red, swollen and painful area of skin, often accompanied by fever and chills.
• Laboratory tests: blood tests for inflammatory markers such as ESR and C-reactive protein, as well as microbiological culture to identify the pathogen.
• Radiologic studies may be used to rule out deep vein thromboembolism if needed.
• Other diagnostic tests may include an ultrasound to assess the condition of nearby lymph nodes.
• Differential diagnosis includes exclusion of other skin and infectious diseases such as dermatitis, cellulitis and allergic reactions.

Treatment

Treatment of erysipelas involves several approaches and depends on the stage and severity of the disease. The main treatment methods include:

• General treatment: bed rest, plenty of fluids and the use of anti-inflammatory drugs.
• Pharmacological treatment: Antibiotics such as penicillin, zithromycin or clarithromycin are prescribed based on the susceptibility of the microorganism.
• Surgical treatment may be required if an abscess or tissue necrosis develops.
• Other treatments may include physical therapy to improve microcirculation and speed up recovery.

List of medications used to treat this disease

The main drugs used to treat erysipelas include:

• Penicillin
• Cephalosporins (eg, cephalexin)
• Macrolides (eg, azithromycin)
• Tetracyclines
• Nonsteroidal anti-inflammatory drugs (eg, Ibuprofen)

Disease monitoring

Monitoring of erysipelas involves regular observation of the patient's condition, especially in the first weeks after the start of treatment. Control stages may include:

• Assessment of the patient's clinical condition: dynamics of symptoms and presence of side effects from medications.
• The prognosis is usually good, but relapses and complications such as abscess or lymphedema are possible.
• Complications may include necrosis, thrombophlebitis, and osteomyelitis.

Age-related features of the disease

Age-related features of erysipelas help to better understand the mechanism of the disease and its consequences. In children, erysipelas may manifest itself more acutely, and they have a high probability of rapid progression of the infection. In older people, the disease may proceed more latent, which complicates diagnosis and leads to higher risks of complications. A long-term recurrent form of the disease is also more often observed in older patients, which requires careful monitoring.

Questions and Answers

• What are the main symptoms of erysipelas? The main symptoms include intense redness of the skin, swelling, tenderness, as well as fever and chills.
• Can you get erysipelas from another person? Yes, erysipelas can be transmitted through contact with skin affected by streptococci, but direct infection from person to person is impossible.
• How long does it take to treat erysipelas? Typically, the course of antibiotic therapy ranges from 7 to 14 days, depending on the severity of the disease and the response to treatment.
• What are the risks of relapse after erysipelas? Relapses can reach 20% within a year, especially in people with chronic diseases, lymphatic disorders or other predisposing factors.
• How to prevent recurrence of erysipelas? Important preventive measures include maintaining personal hygiene, treating underlying diseases and using compression garments to improve venous outflow.

Doctor Oleg Korzhikov recommends paying attention to the following points when treating erysipelas:

1. Monitor your skin regularly, especially in areas where injuries are likely to occur.
2. At the first signs of illness, do not delay contacting a doctor; early diagnosis and treatment play a key role in reducing the risk of complications.
3. Make sure you follow hygiene and relapse prevention recommendations, especially if you have chronic diseases such as diabetes or obesity.
4. Follow the prescribed treatment regimen and do not change the dosage of medications without consulting your doctor, as this may lead to worsening of the condition or relapse.